This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Helps clinicians better identify the presence of opioid abuse or dependence in patients with chronic pain.
Helps patients keep track of their function, pain, sleep, and alcohol/drug use. Allows providers to then use the chart to properly adjust the patient's medications to obtain optimal benefit and to minimize risk to health and safety.
Describes development and validation of a low-literacy, English-language opioid contract.
Uses graphics and a description of the pharmacology to explain buprenorphine in lay terms.
Uses a simple prognostic questionnaire to help clinicians identify modifiable risk factors (biomedical, psychological, and social) for back pain disability. Stratifies patients with the resulting score as low, medium, or high risk and matches patients with a treatment package for each category.
Uses a 20-item instrument administered in an interview format to track behaviors characteristic of addiction related to prescription opioid medications in chronic pain populations. The instrument is scored based on participant responses, interviewer observations of displayed behaviors, and information gathered from medical chart review.
Assesses differences in attractiveness of different prescription opioid products and formulations to potential individuals with substance use disorders.
The LactMed® database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. It includes information on the levels of such substances in breast milk and infant blood, and the possible adverse effects in the nursing infant.
Email Updates